The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of induction systemic mFOLFIRINOX followed by hepatic arterial infusion of floxuridine and dexamethasone given concurrently with systemic mFOLFIRI as a first-line therapy in patients with unresectable liver-dominant intrahepatic cholangiocarcinoma (HELIX-1).
 
Skye C. Mayo
No Relationships to Disclose
 
Ranish K Patel
No Relationships to Disclose
 
Brett S Walker
No Relationships to Disclose
 
Robert Eil
Consulting or Advisory Role - Lyell Immunopharma
Research Funding - Lyell Immunopharma
 
Melissa Wong
No Relationships to Disclose
 
Alice Fung
No Relationships to Disclose
 
Jonathan R Brody
Stock and Other Ownership Interests - Faster Better Media; Perthera
Consulting or Advisory Role - DLP, legal work
Research Funding - Code Biotherapeutics (Inst)
Other Relationship - Editor in chief for Springer and Taylor; IDEAYA Biosciences
 
Sudarshan Anand
No Relationships to Disclose
 
Christopher L. Corless
Employment - Omics Data Automation
Leadership - Omics Data Automation
Stock and Other Ownership Interests - Guardant Health; Omics Data Automation
Honoraria - Roche
Consulting or Advisory Role - Amgen; Cepheid; Deciphera; Roche; Thermofisher Scientific Biomarkers
Research Funding - Aileron Therapeutics (Inst); Arvinas (Inst)
Travel, Accommodations, Expenses - Cepheid; Roche; Thermo Fisher Scientific
 
Lissi Hansen
No Relationships to Disclose
 
Susan Rosenkranz
No Relationships to Disclose
 
Emerson Yu-sheng Chen
Other Relationship - Horizon CME; Taiho Pharmaceutical
 
Guillaume Joe Pegna
Stock and Other Ownership Interests - Amryt Pharma
 
Anna Jackson
No Relationships to Disclose
 
Flavio G. Rocha
Consulting or Advisory Role - AstraZeneca; Histosonics; Medtronic; Oncosil
Travel, Accommodations, Expenses - Lynx Group
 
Emile Latour
No Relationships to Disclose
 
Byung Park
No Relationships to Disclose
 
Charles D. Lopez
Research Funding - Roche/Genentech (Inst); Servier (Inst); Taiho Pharmaceutical (Inst)
 
Shaun Goodyear
Consulting or Advisory Role - PDX Pharmacy
 
Adel Kardosh
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; AstraZeneca; Eisai; Genentech; Seagen
Research Funding - Natera